The p16, a cyclin-dependent kinase inhibitor, acts as a tumor suppressor in most cells (24), but HPV E7 oncoprotein mediates the degradation of retinoblastoma protein (Rb), and p16 exhibits oncogenic activity in HPV-transformed cervical cancer cells (25). This evidence concerns the gene RB1 and neoplasm.